Next gen progestogen-only pill (POP) added to PBS

Oral contraceptive with 24-hour missed pill window added to PBS, along with combination therapy for women with fertility issues Around 80,000 Australian women paying privately for the progestogen-only oral contraceptive Slinda (drospirenone 4mg) will be able to access the medicine under the PBS from 1 May. Women currently pay around $80 for three months’ supply